How Computational Biology Is Reinventing Agriculture & Energy | Ofer Haviv - CEO, Casterra
For decades, agriculture and energy were treated as separate worlds. But what happens when farms become part of the global ...
CEO, Evogene
Search every verified Ofer Haviv interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Ofer Haviv, President and CEO of Evogene, described the company's business strategy and recent developments in a June 2024 company presentation. He stated that Evogene is a publicly traded company on the Tel Aviv Stock Exchange and NASDAQ. Haviv outlined the company's focus on developing life science products based on microbes, small molecules, and genetic elements, using three AI technology engines. He explained that Evogene's business strategy involves forming partnerships through licensing or collaboration with domain-specific companies to develop novel products while reducing financial and development risk. Haviv highlighted a success story involving Evogene's subsidiary, Ctera, which entered into a frame supply agreement with Eni, a major global oil and gas producer, in early 2023. Following this agreement, Ctera received purchase orders for its elite seed varieties totaling over 11 million, expected to be supplied by the end of 2024. In a 2021 interview, Haviv discussed the company's shift in business model starting in 2015, moving from helping partners develop products to developing products internally and spinning out scientist teams into separate legal entities. He also noted that Biomica, another subsidiary, identified four gut microbes (BMC128) that improved the efficacy of PD-1 checkpoint inhibitors in mouse cancer models, with plans to initiate a first-in-human clinical study.
For decades, agriculture and energy were treated as separate worlds. But what happens when farms become part of the global ...
Evogene Company Presentation June 2024, by Ofer Haviv, President & CEO.
Vivienne Parry talks to Ofer Haviv, CEO Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries through the use of the broadly applicable Computational Predictive Biology (CPB) platform. For more healthcare content, visit: https://www.edisongroup.com/our-conte...
Panel discussion at AgriVest 2016 on 27 September 2016. Moderator: Gideon Soesman, GreenSoil Investments Arama Kukutai, Finistere Ventures Ofer Haviv, Evogene Michael Lee, Syngenta Ventures Maarten Goossens, Anterra Capital Bob Grossman, Greenberg Traurig AgriVest 2016 was held on 27 September 2016 at the Weizmann Institute of Science. AgriVest is organized by Trendlines Agtech, GreenSoil Investments, Invest in Israel, part of Israel's Ministry of Economy & Industry. www.agrivestisrael.com
Sign in to search the full transcript archive, filter by topic, and access every quote from Ofer Haviv.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans